Hepatic Injury Global Clinical Trials Review, H1, 2015

Hepatic Injury Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2667CTIDB
  • |
  • Pages: 67
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Hepatic Injury Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Hepatic Injury Global Clinical Trials Review, H1, 2015" provides data on the Hepatic Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatic Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Hepatic Injury 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Clinical Trials by G7 Countries: Proportion of Hepatic Injury to Gastrointestinal Clinical Trials 13

Clinical Trials in G7 Countries by Trial Status 14

Clinical Trials by E7 Countries: Proportion of Hepatic Injury to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase 16

In Progress Trials by Phase 17

Clinical Trials by Trial Status 18

Clinical Trials by End Point Status 19

Unaccomplished Trials of Hepatic Injury 20

Subjects Recruited Over a Period of Time 21

Clinical Trials by Sponsor Type 22

Prominent Sponsors 23

Top Companies Participating in Hepatic Injury Therapeutics Clinical Trials 24

Prominent Drugs 25

Clinical Trial Profiles 26

Clinical Trial Overview of Top Companies 26

Takeda Pharmaceutical Company Limited 26

Clinical Trial Overview of Takeda Pharmaceutical Company Limited 26

Pfizer Inc. 27

Clinical Trial Overview of Pfizer Inc. 27

Ocera Therapeutics, Inc. 28

Clinical Trial Overview of Ocera Therapeutics, Inc. 28

Novartis AG 29

Clinical Trial Overview of Novartis AG 29

McNEIL-PPC, Inc. 30

Clinical Trial Overview of McNEIL-PPC, Inc. 30

Jubilant Life Sciences Limited 31

Clinical Trial Overview of Jubilant Life Sciences Limited 31

Indivior PLC 32

Clinical Trial Overview of Indivior PLC 32

Ikaria Holdings, Inc. 33

Clinical Trial Overview of Ikaria Holdings, Inc. 33

Golden Biotechnology Corp. 34

Clinical Trial Overview of Golden Biotechnology Corp. 34

Cumberland Pharmaceuticals, Inc. 35

Clinical Trial Overview of Cumberland Pharmaceuticals, Inc. 35

Clinical Trial Overview of Top Institutes / Government 36

Children's Medical Center 36

Clinical Trial Overview of Children's Medical Center 36

Chonbuk National University Hospital 37

Clinical Trial Overview of Chonbuk National University Hospital 37

Denver Health and Hospital Authority 38

Clinical Trial Overview of Denver Health and Hospital Authority 38

Hillerod Hospital 39

Clinical Trial Overview of Hillerod Hospital 39

Seoul National University Hospital 40

Clinical Trial Overview of Seoul National University Hospital 40

The First Affiliated Hospital of Sun Yat-sen University 41

Clinical Trial Overview of The First Affiliated Hospital of Sun Yat-sen University 41

Thomas Jefferson University 42

Clinical Trial Overview of Thomas Jefferson University 42

University of Alabama at Birmingham 43

Clinical Trial Overview of University of Alabama at Birmingham 43

University of Texas Southwestern Medical Center at Dallas 44

Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 44

Five Key Clinical Profiles 45

Appendix 65

Abbreviations 65

Definitions 65

Research Methodology 66

Secondary Research 66

About GlobalData 67

Contact Us 67

Disclaimer 67

Source 67

List of Figures

Hepatic Injury Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Hepatic Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Hepatic Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hepatic Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Hepatic Injury Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11

Proportion of Hepatic Injury to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 13

Hepatic Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14

Proportion of Hepatic Injury to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 15

Hepatic Injury Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16

Hepatic Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17

Hepatic Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Hepatic Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Hepatic Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 22

Hepatic Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Hepatic Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24

Hepatic Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

GlobalData Methodology 66

List of Tables

Hepatic Injury Therapeutics, Global, Clinical Trials by Region, 2015* 7

Hepatic Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Hepatic Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hepatic Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Hepatic Injury Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11

Hepatic Injury Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Proportion of Hepatic Injury to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 13

Hepatic Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14

Proportion of Hepatic Injury to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 15

Hepatic Injury Therapeutics, Global, Clinical Trials by Phase, 2015* 16

Hepatic Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17

Hepatic Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Hepatic Injury Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19

Hepatic Injury Therapeutics, Global, Terminated Clinical Trials, 2015* 20

Hepatic Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Hepatic Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 22

Hepatic Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Hepatic Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24

Hepatic Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 26

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 27

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Ocera Therapeutics, Inc., 2015* 28

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 29

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by McNEIL-PPC, Inc., 2015* 30

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Jubilant Life Sciences Limited, 2015* 31

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Indivior PLC, 2015* 32

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Ikaria Holdings, Inc., 2015* 33

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Golden Biotechnology Corp., 2015* 34

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Cumberland Pharmaceuticals, Inc., 2015* 35

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Medical Center, 2015* 36

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Chonbuk National University Hospital, 2015* 37

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Denver Health and Hospital Authority, 2015* 38

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Hillerod Hospital, 2015* 39

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 40

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by The First Affiliated Hospital of Sun Yat-sen University, 2015* 41

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2015* 42

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2015* 43

Hepatic Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2015* 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Hepatic Injury Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Hepatic Injury, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 161900
Site License
USD 5000 INR 323800
Corporate User License
USD 7500 INR 485700

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com